Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $83.56 USD
Change Today +0.15 / 0.18%
Volume 514.7K
DXCM On Other Exchanges
Symbol
Exchange
DXCM is not on other exchanges.
As of 5:20 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martin L. Doordan

Former Director, Member of Compensation Committee and Member of Nominating & Governance Committee, DexCom, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 5 different industries.

72--

Background*

Mr. Martin L. Doordan, Chip has been the President and Chief Executive Officer of Anne Arundel Health System, Inc. since 1994. Mr. Doordan served as the President of Maryland Hospital Association Inc. He served as the President of Anne Arundel Medical Center Inc. from 1988 to October 2009 and served as its Chief Executive Officer until June 30, 2011. He joined Anne Arundel Medical Center in 1972 and oversaw the expansion and construction of a new 104-acre medical park ...

Read Full Background

Corporate Headquarters*

6340 Sequence Drive
San Diego, California 92121

United States

Phone: 858-200-0200
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MA
George Washington University
Unknown/Other Education 1965
University of Delaware
MS
University of Maryland

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DXCM:US $83.56 USD +0.15

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Justin C. Dearborn Chief Executive Officer, President, Corporate Secretary, Director, Member of Executive Committee and Chief Executive Officer of Merge DNA
Merge Healthcare Incorporated
$400.0K
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Patrick J. Sullivan Chief Executive Officer, President and Director
Insulet Corporation
$182.5K
Philip Bowman Chief Executive Officer and Executive Director
Smiths Group plc
1.5M GBP
Kim D. Blickenstaff Chief Executive Officer, President and Director
Tandem Diabetes Care, Inc.
$532.7K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEXCOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.